Standard & Poor’s has affirmed its ‘A-‘ counterparty credit and financial strength ratings and negative outlook on Amedex Insurance Co.
Standard & Poor’s subsequently withdrew the ratings at the company’s request. The ratings reflected Amedex’s good business position as a niche provider of major medical products in Latin America, favorable operating performance, and strong capitalization.
These positive factors are offset by Amedex’s limited size, declining enrollment trends, new business risk through Amedex Bermuda, and high operating expenses, which are the direct consequence of its target market and high level of service provided.
Was this article valuable?
Here are more articles you may enjoy.
Munich Re: Insured Losses From Wildfires, Storms and Floods Hit Record High
Singer’s Elliott Sued by PE Firm in Escalating Fight Over Money
Allianz Built An AI Agent to Train Claims Professionals in Virtual Reality
California Bill Would Require Insurer Claims Handling Plans, And Double Penalties